Pfizer and its German partner BioNTech SE on Tuesday filed an application with US regulators seeking emergency use authorisation for a second booster shot of their COVID-19 vaccine for people aged 65 and older.
US Centers for Disease Control and Prevention data has shown that vaccine efficacy wanes over time and that third shots help restore that efficacy, but it has not released comprehensive data based on age or health status. That analysis was more favourable than a small study of Israeli healthcare workers. When given at least four months after the third shot, a fourth dose was 30 per cent effective against infection for the Pfizer-BioNTech vaccine and 11 per cent for the Moderna vaccine.
Over two years and still considered “EUA” with no clear solution? What emergency? lol. A very convenient excuse to keep it going & potentially making it into a racketeering fraud. Esp when the vaccine is failing badly and designed for Alpha strain not Omicron.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: STForeignDesk - 🏆 4. / 71 Read more »
Source: asiaonecom - 🏆 10. / 59 Read more »
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Source: STForeignDesk - 🏆 4. / 71 Read more »
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Source: STForeignDesk - 🏆 4. / 71 Read more »